Inmode Ltd (INMD) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inmode Ltd   (NASDAQ: INMD)


Inmode Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Inmode Ltd's ROI in the fourth quarter of 2025?
Inmode Ltd achieved a return on average invested assets (ROI) of 13.65 % in its fourth quarter of 2025, which is below Inmode Ltd's average return on investment, which stands at 26.93%.

ROI fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

Within the Healthcare sector 94 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 216 to 594.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -2.76 % -4.82 % -6.76 % -8.6 % -10.35 %
Y / Y Net Income Change TTM -48.24 % -8.41 % -8.41 % -8.41 % -8.41 %
Investment (TTM) in Millions 688 688 688 688 707
Return On Investment (TTM) 13.65 % 26.18 % 25.99 % 25.81 % 25.63 %
INMD's Overall Ranking # 594 # 216 # # #
Seq. Investment Change TTM -0.71 % -0.7 % -0.7 % -0.69 % -2.8 %
Seq. Net Income Change TTM -48.24 % 0 % 0 % 0 % -8.41 %
Net Income (TTM) in Millions 94 181 181 181 181

INMD Company Profile >> Back to INMD Roi Comparisons >> See Annual INMD Return On Investment



Return On Investment INMD's Ranking
Within: No.
Industry # 23
Sector # 95
Overall # 594

Return On Investment Statistics
High Average Low
39.24 %
26.93 %
13.65 %
(Dec 31 2021)   (Dec 31 2025)







Financial Statements
Inmode Ltd's IV. Quarter Investments $ 688 Millions INMD's Balance sheet
Inmode Ltd's IV. Quarter Income $ 94 Millions Quarterly INMD's Income Statement
INMD's Income by Division See INMD's Income by Division


INMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 688 707 789 555 421
Y / Y Investment Growth -2.76 % -10.35 % 42.14 % 31.93 % 61.78 %
Net Income in Millions 94 181 198 162 165
Y / Y Net Income Growth -48.24 % -8.41 % 22.54 % -2.15 % 120.03 %
Annual Return On Investment 13.65 % 25.63 % 25.09 % 29.11 % 39.24 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 13.65 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INMD's Competitors
Subscribers only: Roi for Inmode Ltd's Suppliers
Subscribers only: Return On Investment for INMD's Customers

Other Ratios
INMD's Roa INMD's Inventory Turnover Ratio INMD's Growth Rates INMD's Dividend Statistics
INMD's Profitability Ratios INMD's Asset Turnover Ratio INMD's Dividend Growth
INMD's Roe INMD's Valuation Ratios INMD's Financial Strength Ratios INMD's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Medinotec Inc   37.45 %
Zevra Therapeutics Inc   36.78 %
Oramed Pharmaceuticals Inc  35.86 %
Ptc Therapeutics inc   35.12 %
Mettler toledo International Inc   34.74 %
Newgenivf Group Limited  32.05 %
Eli Lilly And Company  31.62 %
Indivior Pharmaceuticals Inc   31.00 %
Hutchmed china Limited  30.87 %
Medpace Holdings Inc   30.44 %
Adma Biologics Inc   28.75 %
Carlisle Companies Incorporated  27.24 %
Incyte Corporation  27.08 %
Vaxart Inc   26.63 %
Compugen Ltd  26.32 %
Arrowhead Pharmaceuticals Inc   25.56 %
Puma Biotechnology Inc   25.39 %
Catalyst Pharmaceuticals Inc   24.25 %
Iradimed Corporation  22.97 %
Innoviva Inc   22.62 %
Illumina Inc   22.37 %
Transmedics Group Inc   21.99 %
Zoetis Inc   21.25 %
Pro dex Inc   21.04 %
Dexcom Inc   20.78 %
Electromed Inc   20.50 %
Resmed Inc   20.35 %
Merck and Co Inc   20.17 %
Astrazeneca Plc  19.67 %
Vertex Pharmaceuticals Inc  19.48 %

Date modified: 2026-07-07T11:34:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.